Theodore A. Boutacoff Appointed President & CEO of IRIDEX

Thursday, October 18, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

MOUNTAIN VIEW, Calif., Oct. 17 IRIDEXCorporation (Nasdaq: IRIX) announced today that Barry Caldwell has resigned asthe Company's President and Chief Executive Officer, and as a member of theBoard of Directors, effective as of October 16, 2007. The Board of Directorshas appointed Theodore A. Boutacoff, who is currently a member and Chairman ofthe Board of Directors, to serve as the Company's President and ChiefExecutive Officer. Prior to Mr. Caldwell's two year tenure, Mr. Boutacoff hadbeen the Company's President and Chief Executive Officer since co-founding theCompany in 1989.

"Barry has worked hard during his tenure at IRIDEX," Mr. Boutacoffcommented, "We wish him the best of success in his future endeavors."

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic basedlaser systems, disposable laser probes and delivery devices to treat eyediseases in ophthalmology and skin disorders in the aesthetics market. IRIDEXproducts are sold in the United States through a direct sales force andinternationally through a combination of a direct sales force and a network ofapproximately 97 independent distributors into 107 countries.

SOURCE IRIDEX Corporation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store